Skip to main content
. 2023 Apr 21;28(5):1101–1111. doi: 10.1007/s10741-023-10312-7

Table 2.

Main clinical and procedural characteristics of patients with acute decompensate aortic stenosis receiving transcatheter aortic valve replacement

First author, year n Male, n (%) Age (years) STS score (%) NYHA class IV, n (%) Cardiogenic shock, n (%) Femoral access, n (%) Self-expandable valve, n (%) Balloon-expandable valve, n (%) TAVR in degenerated prosthesis, n (%) MCS, n (%)
Landes, 2016 [16] 27 12 (44.5) 80.1 ± 9.7 9.7 17 (63) 0 26 (96.3) 22(81.5) 5(18.5) 0 0
Frerker, 2016 [15] 27 12 (44.5) 78 ± 9 27 (100) 25 (92.5) 16 (59.3) 11 (40.7) 0 0
Kolte, 2018 [12] 3952 2050 (51.8) 84 11.8 2087 (52.8) 97 (2.5) 2980 (75.4) 931 (23.6) 2984 (75.5) 202 (5.1) 47 (1.2)
Abdelaziz, 2018 [8] 76 38 (50) 81.7 ± 6.8 76 (100) 0 64 (84.2) 32(42) 0 0 0
Bongiovanni, 2018 [14] 23 19 (82.6) 76.0 ± 11.4 22 (95.7) 2 (8.7) - 8 (34.8) 15 (65.2) 0 0
Elbadawi, 2020 [11] 10,089 5017 (49.7) 81.0 ± 9.05 8196 (81.2) 348 (3.4)
Patel, 2020 [41] 170 88 (51.8) 83.1 ± 7.6 164 (96.5) 16 (9.4) 143 (84.1) 0 0
Huang, 2019 [64] 31 23 (74.2) 73.1 ± 13.9 26 (83.9) 5 (16.1) 25 (80.6) 16 (51.6)
Fraccaro, 2020 [13] 51 25 (49) 75.8 ± 12.9 19.2 51 (100) 45 (88.2) 30(58.8) 12 (23.5) 13 (25.5) 6 (11.7)
Jalava, 2020 [65] 210 99 (47.1) 80.7 ± 6.6 8.1 210 (100)
Enta, 2020 [39] 87 26 (29.8) 84.9 ± 7.0 13.7 77 (88.5) 72 (82.8) 5(5.8) 82 (94.2) 14 (16.1)
Maidman, 2020 [42] 17 2 (11.7) 74.7 ± 8.9 22.3 15 (88.2) 9 (52.9) 17 (100) 1 (5.9) 16 (94.1) 2 (11.7)
Bianco, 2021 [40] 247 131 (53) 82 148 (59.9) 3 (1.2) 203 (82.2) 144 (58.3) 103 (41.7) 29 (11.7)
Lux, 2021 [66] 53 30 (56.6) 79 36 (67.9) 7 (13.2)
Kaewkes, 2021 [67] 139 74 (53) 82.2 ± 9.6 6.7 132 (95%) 129 (93) 23 (16) 116 (84)

MCS mechanical circulatory support, NYHA New York Heart Association, STS Society of Thoracic Surgeons, TAVR transcatheter aortic valve replacement